Long-term Efficacy of Baricitinib in Adults With Moderate to Severe Atopic Dermatitis Who Were Treatment Responders or Partial Responders: An Extension Study of 2 Randomized Clinical Trials.

Authors

Jonathan I. Silverberg, George Washington University
Eric L Simpson
Andreas Wollenberg
Robert Bissonnette
Kenji Kabashima
Amy M DeLozier
Luna Sun
Tracy Cardillo
Fabio P Nunes
Kristian Reich

Document Type

Journal Article

Publication Date

5-12-2021

Journal

JAMA Dermatology

DOI

10.1001/jamadermatol.2021.1273

Comments

Online ahead of print

APA Citation

Silverberg, J. I., Simpson, E., Wollenberg, A., Bissonnette, R., Kabashima, K., DeLozier, A., Sun, L., Cardillo, T., Nunes, F., & Reich, K. (2021). Long-term Efficacy of Baricitinib in Adults With Moderate to Severe Atopic Dermatitis Who Were Treatment Responders or Partial Responders: An Extension Study of 2 Randomized Clinical Trials.. JAMA Dermatology, (). http://dx.doi.org/10.1001/jamadermatol.2021.1273

Peer Reviewed

1